Cannabis Nano-Formulation for Consistent Drug Delivery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current cannabis products face concerns over side effects and addiction, and existing delivery systems fail to provide consistent and effective delivery of active agents at lower doses.

Innovation Solution

A formulation comprising natural cannabis material, solvent, and stabilizer, forming a liquid suspension with particle sizes below 500 nm, enhancing absorption and stability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional cannabis delivery systems are used, then the active agents can be delivered to patients, but the delivery is inconsistent and requires higher doses to achieve pharmacological effects

Engineering Contradiction:
Improvedelivery consistencyVSAvoiddose requirement
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The cannabis material is ground into fine particles with a maximum size of 500 micrometers, creating a segmented structure that increases surface area and improves dissolution. This segmentation allows for more consistent and reliable delivery of active agents, reducing the dose required to achieve pharmacological effects

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent changes the particle size parameter of cannabis material to a maximum of 500 micrometers and maintains specific pH ranges (6.0-8.0 for aqueous phases, 4.0-6.0 for alcoholic phases). These parameter changes optimize dissolution and absorption, improving delivery consistency and reducing required doses

Inventive Principle:
Principle #35Parameter changes

2Reliability

If cannabis products are used to treat medical conditions, then pharmacological effects can be achieved, but concerns arise regarding side effects and addiction

Engineering Contradiction:
Improvepharmacological effectVSAvoidside effects and addiction
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent optimizes pH parameters (6.0-8.0 for aqueous, 4.0-6.0 for alcoholic phases) and particle size (≤500 μm) to enhance dissolution and absorption efficiency. This allows lower doses to achieve the same pharmacological effect, thereby reducing potential side effects and addiction risks

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent uses food-grade excipients and stabilizers as intermediaries to improve the safety and tolerability of cannabis products. These additives help maintain formulation stability and reduce gastrointestinal irritation, allowing for safer administration

Inventive Principle:
Principle #24Intermediary (Mediator)

3Reliability

If cannabis material is processed into fine particles, then absorption and dissolution are improved, but the complexity of the formulation process increases

Engineering Contradiction:
Improveabsorption and dissolutionVSAvoidformulation process
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The cannabis material is segmented into fine particles (≤500 μm) through grinding, which improves dissolution and absorption. This segmentation is achieved using standard pharmaceutical equipment, balancing improved reliability with manageable process complexity

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Food-grade excipients and stabilizers are introduced as intermediaries to simplify the formulation process. These additives facilitate particle suspension and dissolution without requiring complex processing equipment or procedures

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The formulation ensures safer and more effective delivery of cannabis compounds, providing consistent pharmacological effects at lower doses for treating various medical conditions.

Implementation Method 1

a formulation comprising at least one natural cannabis material, at least one solvent, and at least one stabilizer, wherein the formulation is a liquid suspension having a particle size (D 90) of below 500 nm

Methodology Applied
Scientific EffectDispersion: Dispersion (of waves)

Data Source

PatentEP4176869B1Preparation and use of cannabis nano-formulation
Publication Date: 2026.04.08 APURANO PHARMA
  • EP4176869B1 patent drawingFigure 1
  • EP4176869B1 patent drawingFigure 2
  • EP4176869B1 patent drawing

AI summary

The present application relates to a formulation comprising at least one natural cannabis material, at least one solvent, and at least one stabilizer, wherein the formulation is a liquid suspension having a particle size (D90) of below 500 nm, and the use thereof in the treatment of a disease.